Keywords
tuberculosis
life years adjusted to quality of life
potential lost life years
premature mortality
How to Cite
Abstract
This research estimated the disease load due to tuberculosis in Pereira during 2010-2015. Patients in the tuberculosis program were included in this study. Incidence and disease load indicators were calculated. The study used record cards with management, follow-up and treatment data, patient books, clinical records, and death certificates from the statistical institute DANE. Data processing was conducted using the WHO template and Excel files. During the studied term 1796 cases were entered in the program; potentially lost years of life (AVPP) were calculated as 3753.61. When comparing the data between 2010 and 2015, the cases increased 4.2 times in men and 3.2 in women. The disability-adjusted years of life (AVAD) were higher in men between 30 and 69 years old, 67%. A larger difference between genders was in 2015, 8711.2 healthy years of life were lost (AVISA)). In conclusion, the disease load due to tuberculosis in Pereira y higher regarding the AVPP in men between 15 and 69 years old. It increased significantly between 2010 and 2015.
2. Organización Mundial de la Salud. Global tuberculosis report, 2016. Informe ejecutivo. Ginebra: OMS; 2016.
3. Colombia, Instituto Nacional de Salud. Boletín Epidemiológico Semanal. Bogotá: INS; 2015.
4. Colombia, Gobernación de Risaralda. Comportamiento de los eventos de interés en salud pública. Informativo. Pereira (Colombia): Secretaría Departamental de Salud de Risaralda; 2016.
5. Christopher JL, Murray MD, Phil D, Alan D, López, AD. Measuring the Global Burden of Disease. N Engl J Med. 2013 ag;369. https://doi.org/10.1056/NEJMra1201534
6. Álvarez-Martín E. Estimación de los Años de Vida Ajustados por Discapacidad (AVAD) atribuidos al VIH/sida en España. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2012.
7. Castillo-Rodríguez L, Díaz-Jiménez D, Castañeda-Orjuela C, de la Hoz Restrepo F. Years of Life Lost (YLL) in Colombia 1998-2011: Overall and Avoidable Causes of Death Analysis. PLOS ONE. 2015 my;10(5). https://doi.org/10.1371/journal.pone.0125456
8. Caminero JA, Farga V. Tuberculosis. 3.a ed. Santiago de Chile: Mediterráneo Ltda; 2011.
9. Glaziou P, Sismanidis C, Zignol M, Floyd K. Methods used by WHO to estimate the global burden of TB disease [Internet]. Ginebra: OMS; 2016 [revisión 2018 mzo. 20]. Disponible en: http://www.who.int/tb/publications/global_report/gtbr2016_online_technical_appendix_global_disease_burden_estimation.pdf
10. Tiemersma E, van der Werf M, Borgdorff M, Williams B, Nagelkerke N. Historia Natural de la Tuberculosis: Duración y Fatalidad de la Tuberculosis Pulmonar No Tratada en Pacientes VIH negativos: Una Revisión Sistemática. PLoS ONE. 2011 abr; 6(4).
11. Donev D, Zaletel-Kragelj L, Bjegovic V. Health Investigation: Analysis-Planning-Evaluation. 2.a ed. Lage (Alemania): Jacobs Verlag; 2013. Cap. 1, Measuring the burden of disease: disability adjusted life year (DALY); p. 1-30.
12. Beltrán-Villegas AR, Peñaloza-Quintero RE, Salamanca-Balen N, Rodríguez-García J, Rodríguez-Hernández JM. Estimación de la Carga de Enfermedad para Colombia, 2010. Bogotá: Pontificia Universidad Javeriana; 2010.
13. Kyu HH, Maddison ER, Henry NJ, Mumford JE, Barber R, Shields C, et al. The global burden of tuberculosis: results from the global burden of disease 2015. Lancet Infect Dis. 2018:18:263-284. https://doi.org/10.1016/S1473-3099(17)30703-X
14. Colombia, Instituto Nacional de Salud. Boletín Epidemiológico Semanal (BES), Una mirada hacia el comportamiento de la Tuberculosis en Colombia, 2018 (semanas epidemiológicas 1-36) [Internet]. Disponible en: https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2018%20Bolet%C3%ADn%20epidemiol%C3%B3gico%20semana%2038.pdf
15. Perú, Ministerio de Salud. Análisis de la situación epidemiológica de la tuberculosis en el Perú, 2015. Lima: MINSA; 2015.
16. Colombia, Instituto Nacional de Salud. Boletín Epidemiológico Semanal N.° 52. Bogotá: INS; 2015.
17. López-Pelayo I, García-Martos P, Saldarreaga A, Montes de Oca M, Moreno I, González-Moya E. Características de la tuberculosis en pacientes mayores de 65 años en el área sanitaria de Cádiz (España). Rev Med Chile. 2004 mzo; 132(3).
18. Rodríguez MS. Tuberculosis en pacientes ancianos. Anal Medic Int. 2002 mzo; 19(3).
19. Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, Dye C, Unwin N. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health. 2007 sep; 7:234. https://doi.org/10.1186/1471-2458-7-234
20. Organización Mundial de la Salud. Hablemos de tuberculosis y VIH [Internet]. 2018 [revisión 2018 mzo. 12]. Disponible en: http://www.who.int/tb/challenges/hiv/talking_points/es/
21. Muñoz del Carpio-Toia A, Sánchez-Pérez HJ, Verges de López C, López-Dávila LM, Sotomayor-Saavedra MA, Sorokin P. Tuberculosis en América Latina y el Caribe: reflexiones desde la bioética. Pers. Bioét. 2018;22(2):331-357. https://doi.org/10.5294/pebi.2018.22.2.10
22. Colombia, Ministerio de Salud y Protección Social. Análisis de Situación de Salud de la Dimensión Vida Saludable y Condiciones Transmisibles. Bogotá: Ministerio de Salud y Protección Social de Cundinamarca; 2016.
23. Instituto Para La Medición y Evaluación De La Salud. La Carga Mundial Morbilidad: Generar Evidencias, Orientar Políticas. Informe Ejecutivo n.° ISBN 978-0-9894752-8-0. Washington: Universidad de Washington; 2010.
24. Marlow MA, Maciel EL, Sales CM, Gomes T, Snyder RE, Daumas RP, et al. Tubserculosis DALY-gap: spatial comparison of disease burden across urban slum an non slum census tracts. J Urban Health. 2015 ag;92(4):622-634. https://doi.org/10.1007/s11524-015-9957-0
25. Seok-Jun Y, Young-Eun K, Eun-Jung K. Why They Are Different: Based on the Burden of Disease Research of WHO and Institute for Health Metrics and Evaluation. Biomed Res. Int. 2018: 1-4. https://doi.org/10.1155/2018/7236194
Copyright notice
The Journal Management and Health Policies is registered under the Creative Commons Recognition 4.0 International license. Therefore, this work can be reproduced, distributed and publicly communicated in digital format, provided that the name of the authors and the Pontificia Universidad Javeriana are recognized. It is allowed to quote, adapt, transform, autoarchive, republish and create from the material, for any purpose (including commercial), provided that authorship is properly acknowledged, a link to the original work is provided and if changes have been mad. The Pontificia Universidad Javeriana does not retain the rights over published works and the contents are the exclusive responsibility of the authors, who preserve their moral, intellectual, privacy and publicity rights.
The endorsement of the intervention of the work (revision, style correction, translation, layout) and its subsequent disclosure is granted through a license to use and not through a transfer of rights, which means that the journal and the Pontificia Universidad Javeriana disclaims any liability that may arise from ethical misconduct on the part of the authors. As a result of the protection provided by the license for use, the journal is not obliged to publish retractions or modify the information already published, unless the erratum arises from the process of editorial management. The publication of contents in this magazine does not represent royalties for taxpayers.